IEFM
PRME icon

IQ EQ Fund Management’s Prime Medicine PRME Stock Holding History

IQ EQ Fund Management’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$833K Buy
225,799
+20,410
+10% +$67.8K 0.05% 238
2026
Q1 		$715K Buy
205,389
+26,870
+15% +$102K 0.05% 231
2025
Q4 		$619K Buy
178,519
+57,746
+48% +$257K 0.04% 241
2025
Q3 		$669K Buy
120,773
+87,113
+259% +$354K 0.05% 244
2025
Q2 		$83.1K Sell
33,660
-56,210
-63% -$86.6K 0.01% 305
2025
Q1 		$179K Buy
89,870
+29,185
+48% +$74.5K 0.02% 286
2024
Q4 		$177K Buy
60,685
+32,572
+116% +$114K 0.02% 274
2024
Q3 		$109K Buy
28,113
+9,199
+49% +$42.6K 0.01% 315
2024
Q2 		$97.2K Buy
+18,914
New +$115K 0.01% 302

Other funds holding PRME

Alphabet Inc
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Woodline Partners
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

IQ EQ Fund Management's PRME Position: Q2 2026 in Review

IQ EQ Fund Management increased its Prime Medicine (PRME) stake by 9.9% in Q2 2026, buying an estimated $67.8K and bringing the position to 225,799 shares worth $833K. The position accounts for 0.05% of the portfolio, ranked #238.

IQ EQ Fund Management first reported a position in PRME in Q2 2024 and has held it in 9 quarters since. 187 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • IQ EQ Fund Management held 225,799 shares of Prime Medicine worth $833K as of Q2 2026.
  • IQ EQ Fund Management bought 20,410 Prime Medicine shares in Q2 2026, an estimated $67.8K.
  • Prime Medicine made up 0.05% of IQ EQ Fund Management's portfolio in Q2 2026, its #238 holding.
  • IQ EQ Fund Management first reported a position in Prime Medicine in Q2 2024 and has held it in 9 quarters since.
  • 187 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on IQ EQ Fund Management's 13F filing for Q2 2026, filed 31 Jul 2026.